Having a heart condition, such as obstructive hypertrophic cardiomyopathy (HCM), can affect your daily life in a number of ways. For example, what may seem like a normal errand or regular gym workout ...

While obstructive hypertrophic cardiomyopathy (oHCM) is a structural heart issue, what you eat and drink can affect how that structure functions — and how you feel as you go about your daily ...

Camzyos (mavacamten) is a prescription drug that works to treat obstructive hypertrophic cardiomyopathy (HCM) by relaxing your heart muscle, allowing it to pump blood more easily. Doctors prescribe ...

Living with any kind of heart-related disease can be worrisome, especially one with a range of symptoms, such as obstructive hypertrophic cardiomyopathy (HCM). This genetic condition causes a ...

Please provide your email address to receive an email when new articles are posted on . Aficamten improved peak oxygen uptake at 24 weeks vs. metoprolol in patients with obstructive hypertrophic ...

You can manage the risks of hypertrophic cardiomyopathy (HCM) with treatment and lifestyle changes. Here’s how to make the most of your next medical checkup. HCM is a genetic condition in which the ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved aficamten to improve functional capacity and symptoms in adults with obstructive hypertrophic ...

NEW ORLEANS, LA—Mavacamten (Camzyos; Bristol Myers Squibb) better reduces left ventricular outflow tract (LVOT) obstruction than placebo among adolescent patients with obstructive hypertrophic ...

Cytokinetics, Incorporated announced findings from two analyses of the SEQUOIA-HCM trial that studied the effects of aficamten on patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM ...

MADRID, Spain—For patients with hypertrophic cardiomyopathy (HCM), research presented today at the European Society of Cardiology (ESC) Congress 2025 demonstrated both the promise and the potential ...